🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A key message from #mascc25: When selecting #IntegrativeTherapy, rely on the robust #IntegrativeOncology guidelines from @IntegrativeOnc and ASCO. Their development process is rigorously evidence-based, ensuring reliable guidance for all.

Many people with #cancer are treated with drugs called immune checkpoint inhibitors. #ClinicalTrial S2013 #ICHECKIT may help us predict who is at risk for side effects from these drugs. Learn more: SWOG.org/S2013. Or call 1-800-4-CANCER. Ask about S2013.

💸 Why Financial Toxicity (#FinTox) matters in cancer care Key insights from Dr Fumiko Ladd Chino, MD, FASCO’s excellent plenary at #MASCC25 : 🔻 It erodes quality of life and social functioning 📉 Leads to borrowing, reduced spending on basics and leisure; the burden worsens over time 💥

Inavolisib triplet approval marks real progress for pts w/ PIK3CA-mut HR+ mBC With progress come new questions—on pt selection, toxicity & integration into practice In this article we break down the data and its implications doi.org/10.1200/OA-25-… Dana-Farber’s Breast Oncology Center OncoAlert

Incredible opportunities for #YoungOncologists at #ESMOGI25! Don’t miss learning from the experts! ✨🌟 ESMO - Eur. Oncology #ESMOAmbassadors

Ipi/nivo vs VEGF TKI in non-clear cell RCC Annals of Oncology The 1st randomised IO data in these cancers, establishing IO. It’s +ve but not overwhelming. Some minor design issues too.VEGF/PD1 combos are probably better, but those studies were not randomised sciencedirect.com/science/articl…

Our team Penn Medicine Penn Medicine - Abramson Cancer Center is recruiting two medical oncologists for our Princeton site in New Jersey. I am leading the recruitment efforts. Focus areas include Breast, GU, and Hematologic Malignancies. Please message me if interested or if you'd like to learn more

#ESMOGI25 orals: MATTERHORN PROs are here 👏: - PRO compliance rate high ✅ - No decline in QOL with FLOT + D - Anxiety 📉 after therapy #ESMOAmbassadors ESMO - Eur. Oncology Salah-Eddin Al-Batran

🎉 We're so excited to have Kimryn Rathmell The James join us in conversation during the KCA's Women in RCC summer webinar next month! 👉Register today:bit.ly/3Gf9wgV

🎉 5 new sites activated for the clinical trial CARE1! We now have 45 open centers across 3 countries. A huge thank you to all our partners for making this possible! 🌍👏 #ClinicalTrials #CARE1PCT

Welcome to our newest sites: 🏥 Centre Leon Berard 🏥 Métropole Savoie (site de Chambéry) 🏥 CH Mont de Marsan 🏥 CHU de Limoges 🏥 CHU de Brest We’re thrilled to have you on board! 🙌 #ClinicalResearch #TeamWork #CARE1PCT #CARE1Project #kidneycancer

📲 2026 ASCO Special Awards nominations are open until July 11, 2025. ASCO members can earn up to 2 FASCO points by submitting a nomination. Submit one today! brnw.ch/21wTSs4

1/ Recently, our lab has worked with outstanding groups (#TeamScience) to address some key questions in kidney cancer immunobiology: Can we use machine-learning approaches to classify RCC and predict response? Cancer Cell What drives exceptional response with immunotherapies?

At #MASCC25, we were pleased to congratulate our new Supportive Care 2030 Movement - President Training Fellowship recipients: Dr Colleen Cuthbert, Celia Díez De los Ríos, Dr Jeff Hanna, Chia Jie Tan, Dr. Alique Topalian, Julien Vos, and Yanfei Wang. Read more here: mascc.org/2025-president…

Dr Kelsey Lau-Min bringing us some amazing #pallonc AND #GIonc wisdom alongside all-star 🤩 co-authors Ryan Nipp, MD, MPH, MBA, FASCO Aparna Raj Parikh Areej El-Jawahri #Temel for The Oncologist #LARC pts and caregivers face major challenges ⭐️Complex Tx 🔪💉☢️ ⭐️#QoL impacts, ⭐️ ⬆️ #supponc care needs Unique

So fun to talk about palliative care and survivorship with friends on GeriPal - A Geriatrics & Palliative Care Podcast! Should PC clinicians provide survivorship care? Give it a listen & weigh in! #survonc Larissa Nekhlyudov Ryan Nipp, MD, MPH, MBA, FASCO Cristiane D Bergerot Nicolas Hart Nicole L. Stout DPT, FAPTA Jill Feldman Ramy Sedhom, MD, FASCO Maryam Lustberg MD, MPH, FASCO

Pleased to have COSA endorsement of the MASCC and ASCO Standards and Practice Recommendations for Advanced or Metastatic Cancer Survivorship Care: onlinelibrary.wiley.com/doi/epdf/10.11…. In this editorial, we offer implementation and future optimal care considerations.

A whole new batch of CRANELab staff and students certified for clinic visits to support our National Cancer Institute, The Patient-Centered Outcomes Research Institute, and FLDOH #lifestylemedicine trials Sylvester Comprehensive Cancer Center!!!

Radiation Oncology, Urology, and Medical Oncology — a multidisciplinary team against prostate cancer. Grateful for the insights Regina Barragan-Carrillo 🥰

Laura Petrillo 🗽 GeriPal - A Geriatrics & Palliative Care Podcast Ryan Nipp, MD, MPH, MBA, FASCO Cristiane D Bergerot Nicolas Hart Nicole L. Stout DPT, FAPTA Jill Feldman Ramy Sedhom, MD, FASCO Maryam Lustberg MD, MPH, FASCO I am with you! As I have often emphasized, it doesn’t matter WHO addresses the holistic needs cancer survivors, as long as these are addressed. #SurvOnc